Skip to content

perioperative effects of dexmedetomidine

Evaluation of The Effects of a Single Preoperative Dexmedetomidine Dose in Patients Undergoing Anterior Cervical Discectomy: (A Randomized Controlled Trial)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202510879446766
Enrollment
52
Registered
2025-10-30
Start date
2024-03-04
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

20 ml of normal saline before standardized general anesthesia for ACDF
group D. intravenous dexamedetomidine

Sponsors

anesthesia department. facylty of medicine meniudia university egypt
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: • Patients aged between 18-60 years’ old • ASA physical status I- II, of either sex • Elective anterior cervical discectomy and fusion under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Pre-existing bradycardia [heart rate (HR) below 50/min]. 2. Hypotension (systolic arterial pressure 140/90) 4. Planned elective postoperative ventilation; poor respiratory reserve and poor cough reflex. 5. Presence of cardiac, renal, hepatic, neurological and respiratory dysfunction; cognitive impairment. 6. Known allergy to a2 -agonists. 7. Use of ß-blockers, digoxin, , or a2 -agonists.

Design outcomes

Primary

MeasureTime frame
the time to emergence from general anesthesia.

Secondary

MeasureTime frame
intraoperative parameters (consumption of propofol, isoflurane, and fentanyl), the quality of emergence (assessed by coughing/bucking severity and sedation scores), postoperative pain profiles (VAS scores and analgesic requirements), the incidence of nausea and vomiting (PONV), time to meet PACU discharge criteria, and the overall rate of adverse events.

Countries

Egypt

Contacts

Public Contactmohamed soliman

lecturer of anesthesiology

mohamed_soliman@gmail.com0020106938776

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026